期刊文献+

原发性系统性轻链淀粉样变1例并文献复习

Primary systemic light chain amyloidosis: a case report and literature review
原文传递
导出
摘要 原发性系统性淀粉样变是由于淀粉样蛋白沉积于细胞外基质,造成沉积部位组织和器官损伤的一组疾病.可累及肾、心脏、肝、皮肤、神经和肺等脏器或组织.淀粉样物质成分有多种,如免疫球蛋白轻链、血清淀粉样A蛋白和转甲状腺素等.最常见的为原发性系统性轻链淀粉样变性,系骨髓内浆细胞产生的单克隆免疫球蛋白轻链或轻链片段,以淀粉样蛋白沉积造成的.该病临床罕见,且容易误诊.本文总结1例被误诊的原发性轻链型淀粉样变(primary light chain amyloidosis,pAL)患者,并通过复习相关文献加深对此病诊治的认识,在临床诊疗中需提高警惕.
作者 单士龙 楚玉兰 贾晓冬 陈建春 周剑峰 Shan Shilong;Chu Yulan;Jia Xiaodong
出处 《中华临床实验室管理电子杂志》 2019年第4期254-256,共3页 Chinese Journal of Clinical Laboratory Management(Electronic Edition)
作者简介 通信作者:单士龙,Email:shanshilong-2121@163.com。
  • 相关文献

参考文献1

二级参考文献24

  • 1Gillmore JD, Wechalekar A, Bird J, et al. Guidelines on the diagnosis and investigation of AL amyloidosis [J]. Br J Haematol, 2015, 168(2): 207-218.
  • 2Gertz MA. Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment [J]. Am J Hematol, 2014, 89(12): 1132-1140.
  • 3Comenzo RL, Reece D, Palladini G, et al. Consensus guidelines for the conduct and reporting of clinical trials in systemic light- chain amyloidosis [J]. Leukemia, 2012, 26 (11): 2317-2325.
  • 4Dispenzieri A, Kyle R, Merlini G, et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders [J]. Leukemia, 2009, 23(2): 215-224.
  • 5Leung N, Nasr SH, Sethi S. How 1 treat amyloidosis: the impor- tance of accurate diagnosis and amyloid typing [ J]. Blood, 2012, 120( 16): 3206-3213.
  • 6Dispenzieri A, Gertz MA, Kyle RA, et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis [J]. J Clin Oncol, 2004, 22( 18): 3751-3757.
  • 7Kumar S, Dispenzieri A, Lacy MQ, et al. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements [J]. J Clin Oncol, 2012, 30(9): 989-995.
  • 8Palladini G, Dispenzieri A, Gertz MA, et al. New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes [J]. J Clin Oncol, 2012, 30(36):4541-4549.
  • 9Leung N, Glavey SV, Kumar S, et al. A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision? [J]. Haematologica, 2013, 98 (6): 988-992.
  • 10Girnius S, Seldin DC, Cibeira MT, et al. New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dosemelphalan and autologous stem-cell transplantation [J]. J Clin Oncol, 2013, 31 (21): 2749-2750.

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部